The effects of leptin on human cytotrophoblast invasion are gestational age and dose-dependent

Front Endocrinol (Lausanne). 2024 May 23:15:1386309. doi: 10.3389/fendo.2024.1386309. eCollection 2024.

Abstract

Introduction: Leptin and its receptors are expressed by the human placenta throughout gestation, yet the role of leptin in early human placental development is not well characterized. Leptin is overexpressed in the placentas from preeclamptic (PE) pregnancies. PE can result from the impaired invasion of fetal placental cells, cytotrophoblasts (CTBs), into the maternal decidua. We hypothesized that elevated leptin levels would impair human CTB invasion.

Methods: The effects of leptin on the invasion of human CTBs were evaluated in three cell models, HTR-8/SVneo cells, primary CTBs, and placental villous explants using invasion assays. Further, leptin receptor expression was characterized in all three cell models using RT-PCR. Further phosphokinase assays were performed in HTR-8/SVneo cells to determine signaling pathways involved in CTB invasion in response to differential leptin doses.

Results: We found that, prior to 8 weeks gestation, leptin promoted CTB invasion in the explant model. After 11 weeks gestation in explants, primary CTBs and in HTR-8/SVneo cells, leptin promoted invasion at moderate but not at high concentrations. Further, leptin receptor characterization revealed that leptin receptor expression did not vary over gestation, however, STAT, PI3K and MAPK pathways showed different signaling in response to varied leptin doses.

Discussion: These data suggest that the excess placental leptin observed in PE may cause impaired CTB invasion as a second-trimester defect. Leptin's differential effect on trophoblast invasion may explain the role of hyperleptinemia in preeclampsia pathogenesis.

Keywords: invasion; leptin; leptin receptor; placenta; preeclampsia; trophoblast.

MeSH terms

  • Cell Movement / drug effects
  • Dose-Response Relationship, Drug
  • Female
  • Gestational Age*
  • Humans
  • Leptin* / metabolism
  • Leptin* / pharmacology
  • Placenta / drug effects
  • Placenta / metabolism
  • Placenta / pathology
  • Placentation / drug effects
  • Pre-Eclampsia / metabolism
  • Pre-Eclampsia / pathology
  • Pregnancy
  • Receptors, Leptin* / genetics
  • Receptors, Leptin* / metabolism
  • Signal Transduction
  • Trophoblasts* / drug effects
  • Trophoblasts* / metabolism
  • Trophoblasts* / pathology

Substances

  • Leptin
  • Receptors, Leptin
  • LEPR protein, human

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by National Institutes of Health Grants TL1 RR025778 (KR), K12 HD001271 (VW), RO1 HD060723 (VW), March of Dimes Basil O’Conner Award FY08-84 (VW) Stanford Maternal and Child Health Research Institute Arline and Pete Harman Endowed Faculty Scholar (VW), H & H Evergreen Fund (VW).